Search
for
Sort by
Research 151–180 of 261
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- The JAK/STAT signaling pathway: from bench to clinic
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Rapidly progressing mycosis fungoides presenting as follicular mucinosis
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Immunofluorescent findings and clinical overlap in two cases of follicular lichen planus
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Immune therapies for alopecia areata: evidence and new perspectives
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review